Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin‐Q
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND G protein‐coupled inwardly rectifying potassium (K IR 3) channels are important proteins that regulate numerous physiological processes including excitatory responses in the CNS and the control of heart rate. Flavonoids have been shown to have significant health benefits and are a diverse source of compounds for identifying agents with novel mechanisms of action. EXPERIMENTAL APPROACH The flavonoid glycoside, naringin, was evaluated on recombinant human K IR 3.1–3.4 and K IR 3.1–3.2 expressed in Xenopus oocytes using two‐electrode voltage clamp methods. In addition, we evaluated the activity of naringin alone and in the presence of the K IR 3 channel blocker tertiapin‐Q (0.5 nM, 1 nM and 3 nM) at recombinant K IR 3.1–3.4 channels. Site‐directed mutagenesis was used to identify amino acids within the M1–M2 loop of the K IR 3.1 F137S mutant channel important for naringin's activity. KEY RESULTS Naringin (100 µM) had minimal effect on uninjected oocytes but activated K IR 3.1–3.4 and K IR 3.1–3.2 channels. The activation by naringin of K IR 3.1–3.4 channels was inhibited by tertiapin‐Q in a competitive manner. An alanine‐scan performed on the K IR 3.1 F137S mutant channel, replacing one by one aromatic amino acids within the M1–M2 loop, identified tyrosines 148 and 150 to be significantly contributing to the affinity of naringin as these mutations reduced the activity of naringin by 20‐ and 40‐fold respectively. CONCLUSIONS AND IMPLICATIONS These results show that naringin is a direct activator of K IR 3 channels and that tertiapin‐Q shares an overlapping binding site on the K IR 3.1–3.4. This is the first example of a ligand that activates K IR 3 channels by binding to the extracellular M1–M2 linker of the channel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Hertog, M. G. L. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430040053006 · Cited by 1,853 · cited 1×
“They have been shown to reduce heart disease (Renaud and de Lorgeril, 1992), be protective against cancers (Kandaswami et al., 1991; Hertog et al., 1995) and neurodegenerative diseases such as Alzheimer’s disease (Mandel and Youdim, 2004).”
BackgroundLüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617 · cited 2×
“Such channels have been implicated in pain perception and in the pathophysiology of several diseases such as epilepsy and ataxia (Luscher and Slesinger, 2010).”
Background
Cited by
Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
Bhullar, K. S., & Rupasinghe, H. P. V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/891748 · Cited by 411
Wydeven, N., Marron Fernandez de Velasco, E., Du, Y., Benneyworth, M. A., Hearing, M. C., Fischer, R. A., Thomas, M. J., Weaver, C. D., & Wickman, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405190111 · Cited by 109
“GIRK channels are also activated in a G-protein–independent manner by ethanol (6, 7), volatile anesthetics (8, 9), and naringin (10).”
BackgroundJeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89
Djebari, S., Iborra-Lázaro, G., Temprano-Carazo, S., Sánchez-Rodríguez, I., Nava-Mesa, M. O., Múnera, A., Gruart, A., Delgado-García, J. M., Jiménez-Díaz, L., & Navarro-López, J. D. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2849-20.2021 · Cited by 48
Advances in Targeting GIRK Channels in Disease
Zhao, Y., Gameiro-Ros, I., Glaaser, I. W., & Slesinger, P. A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.12.002 · Cited by 44
Metadata
- Authors
- Yow, T. T., Pera, E., Absalom, N., Heblinski, M., Johnston, G. A., Hanrahan, J. R., & Chebib, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-06-08
- Volume
- 163
- Issue
- 5
- Pages
- 1017-1033
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2152975224
- Cited by
- 58
- References
- 3
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin‐Q. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01315.x
- The paper
- Yow, T. T., Pera, E., Absalom, N., Heblinski, M., Johnston, G. A., Hanrahan, J. R., & Chebib, M. (2011). Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin‐Q. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01315.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.